400 related articles for article (PubMed ID: 21720501)
21. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
Li X; Xu Y; Chen G; Wei P; Ping Q
Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
Ravi Kumar MN; Bakowsky U; Lehr CM
Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
[TBL] [Abstract][Full Text] [Related]
23. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
24. An implantable smart magnetic nanofiber device for endoscopic hyperthermia treatment and tumor-triggered controlled drug release.
Sasikala ARK; Unnithan AR; Yun YH; Park CH; Kim CS
Acta Biomater; 2016 Feb; 31():122-133. PubMed ID: 26687978
[TBL] [Abstract][Full Text] [Related]
25. Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin.
Ertl B; Platzer P; Wirth M; Gabor F
J Control Release; 1999 Sep; 61(3):305-17. PubMed ID: 10477803
[TBL] [Abstract][Full Text] [Related]
26. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
27. Poly(lactic-co-glycolic) Acid/Solutol HS15-Based Nanoparticles for Docetaxel Delivery.
Cho HJ; Park JH; Kim DD; Yoon IS
J Nanosci Nanotechnol; 2016 Feb; 16(2):1433-6. PubMed ID: 27433600
[TBL] [Abstract][Full Text] [Related]
28. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
Avgoustakis K
Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
[TBL] [Abstract][Full Text] [Related]
29. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
Mehta AK; Yadav KS; Sawant KK
Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
[TBL] [Abstract][Full Text] [Related]
30. Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization.
Chen W; Lu DR
J Microencapsul; 1999; 16(5):551-63. PubMed ID: 10499836
[TBL] [Abstract][Full Text] [Related]
31. [Advance in the study of poly(lactide-co-glycolide) nano/microparticles as gene vector].
Zeng P; Peng ML; Xu Y
Yao Xue Xue Bao; 2010 Nov; 45(11):1346-53. PubMed ID: 21361033
[TBL] [Abstract][Full Text] [Related]
32. Ibuprofen-loaded poly(lactic-co-glycolic acid) films for controlled drug release.
Pang J; Luan Y; Li F; Cai X; Du J; Li Z
Int J Nanomedicine; 2011; 6():659-65. PubMed ID: 21674021
[TBL] [Abstract][Full Text] [Related]
33. Folic acid functionalized nanoparticles for enhanced oral drug delivery.
Roger E; Kalscheuer S; Kirtane A; Guru BR; Grill AE; Whittum-Hudson J; Panyam J
Mol Pharm; 2012 Jul; 9(7):2103-10. PubMed ID: 22670575
[TBL] [Abstract][Full Text] [Related]
34. Poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped trans-cinnamaldehyde and eugenol for antimicrobial delivery applications.
Gomes C; Moreira RG; Castell-Perez E
J Food Sci; 2011 Mar; 76(2):N16-24. PubMed ID: 21535781
[TBL] [Abstract][Full Text] [Related]
35. Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.
Joung YK; Son S; Jang JY; Kwon MH; Park KD
Pharm Res; 2012 Apr; 29(4):932-42. PubMed ID: 22139535
[TBL] [Abstract][Full Text] [Related]
36. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
[TBL] [Abstract][Full Text] [Related]
37. PLGA nanoparticles in drug delivery: the state of the art.
Bala I; Hariharan S; Kumar MN
Crit Rev Ther Drug Carrier Syst; 2004; 21(5):387-422. PubMed ID: 15719481
[TBL] [Abstract][Full Text] [Related]
38. Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells.
Huang F; You M; Chen T; Zhu G; Liang H; Tan W
Chem Commun (Camb); 2014 Mar; 50(23):3103-5. PubMed ID: 24516863
[TBL] [Abstract][Full Text] [Related]
39. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC
Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
[TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
